(Press-News.org) The 15th World Congress on Targeting Mitochondria is set to take place in Berlin from October 28-30, 2024, promising a platform for front-line discussions and major insights into mitochondrial research.
Prof. Volkmar Weissig, president of the World Mitochondria Society stated: "In this 15th edition, we'll explore the fundamental and mechanistic research of mitochondria. But what really sets this year apart is our special focus on how mitochondria can be applied in real-world medical settings. We'll be exploring how these tiny powerhouses have the potential to completely transform the future of healthcare, making this congress a one-of-a-kind opportunity to bridge the gap between scientific understanding and practical medical advancements.”
“What truly distinguishes this year is our dedicated focus on applying mitochondria in real-world medical scenarios, including innovative techniques like mitochondria transplantation and transfer. These cutting-edge approaches hold immense promise for addressing various medical conditions and advancing therapeutic interventions” Explained Prof. Marvin Edeas, chairman of the WMS scientific committee.
Summary of the Agenda
Day 1 - Monday, October 28, 2024: Mitochondria Workshop
Workshop Title: “How to Evaluate Mitochondria Function? Bridging Theory and Practice”
Led by: Dr. Naïg Gueguen, MitoVasc Institute, Angers University Hospital Center, France.
Focus: Methodologies and techniques for assessing mitochondrial function accurately.
Day 2 - Tuesday, October 29, 2024: Keynote and Sessions
Keynote Presentation: “The Mitochondrial Kingdom: Historical Moments, Evolutionary Insights, Current Understanding, and Future Projections.”
Session 1: Mitochondrial Biodynamics in Health and Diseases
Topics include mitochondrial mitophagy and biogenesis, mitochondria in cancer, aging, cell communication, and the interconnections between iron, ferritin, and mitochondria.
Session 2: Evaluation and Quality Control of Mitochondrial Function
Highlights innovations in mitochondrial function measurement, real-time visualization techniques, new monitoring devices, and quality control mechanisms.
Day 3 - Wednesday, October 30, 2024: Continuing Sessions and Concluding Remarks
Session 3: 15th World Mitochondria Society Meeting on Emerging Trends and Strategies
Covers exosomes and extracellular vesicles, AI in research, mitochondria-microbiota interplay, updates on mitochondria in photomedicine, and considerations of Chinese medicine.
Session 4: Mitochondrial Medicine 2024: From Bench to Bedside
Focuses on practical applications like mitochondrial transplantation, transfer & tunneling nanotubes, pharmaceutical approaches, and the latest clinical studies targeting mitochondria.
Concluding Remarks & Awards: Summarizing key takeaways, next steps in mitochondrial research, and recognizing outstanding contributions.
For more information and direct updates about the program and speakers, please visit Website and LinkedIn.
You can also access previous World Mitochondria Society meetings to learn about the talks, awards, and replay. Previous Conferences.
About WMS
The World Mitochondria Society, established in 2010, is dedicated to addressing the evolving challenges in mitochondrial research with a forward-thinking agenda. Under the leadership of President Volkmar Weissig and Founder Marvin Edeas, we prioritize Emerging Trends and Strategies to stimulate innovative discussions and explore new avenues in mitochondrial science.
Join our community of over 3200 members from various fields related to mitochondria and health to contribute and benefit from our collective expertise. Membership Details.
END
Join the World Mitochondria Society in Berlin for their 15th Annual Meeting: Emerging Trends & Strategies
2024-02-14
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Novel drug combination shows promise for advanced her2-negative breast cancer
2024-02-14
FOR IMMEDIATE RELEASE
A novel three-drug combination achieved notable responses in patients with advanced HER2-negative breast cancer, according to new research directed by investigators from the Johns Hopkins Kimmel Cancer Center. The treatment included a histone deacetylase (HDAC) inhibitor — a drug that causes a chemical change to stop tumor cells from dividing — with two types of immunotherapy known as checkpoint inhibitors, which unharness the power of the immune response against cancer.
The multicenter ...
Key genes linked to DNA damage and human disease uncovered
2024-02-14
More than one hundred key genes linked to DNA damage have been uncovered through systematic screening of nearly 1,000 genetically modified mouse lines, in a new study published today (14 February) in Nature.
The work provides insights into cancer progression and neurodegenerative diseases as well as a potential therapeutic avenue in the form of a protein inhibitor.
The genome contains all the genes and genetic material within an organism's cells. When the genome is stable, cells can accurately replicate and divide, passing on correct genetic ...
New study finds Black birthing people prefer Black obstetric providers due to experiences of discrimination and fear of dying during pregnancy or childbirth
2024-02-14
UNDER EMBARGO UNTIL: Feb. 14, 2024, 11:45 AM EST
Media Contacts: Karen Addis, APR, karen@addispr.com, +1 (301) 787-2394; Kerri Wade, MPA, kwade@smfm.org, +1 (202) 236-1780
National Harbor, Md. -- Data from the Centers for Disease Control and Prevention demonstrate that Black women in the United States are three times more likely to die from a pregnancy-related cause than are white women. Health disparities among people of color are the result of broader social and economic inequities rooted in racism and discrimination.
In a new study to be presented today at the Society for Maternal-Fetal Medicine’s (SMFM) annual meeting, The Pregnancy Meeting™, researchers ...
SLAS Life Sciences and Technology Awards announced
2024-02-14
Boston, MA (February 13, 2024) – Science and technology awards were announced during the SLAS2024 International Conference and Exhibition, the annual flagship event of the Society for Laboratory Automation and Screening, which attracted a record-setting 7500 attendees and 400 exhibitors. Each year SLAS recognizes several exceptional presenters and exhibitors who represent the best of the Society’s programs and mission. The complete list of the 2024 award descriptions and winners follow:
SLAS Innovation Award
The most ...
Is the Amazon forest approaching a tipping point?
2024-02-14
Global warming may be interacting with regional rainfall and deforestation to accelerate forest loss in the Amazon, pushing it towards partial or total collapse.
Research published today [14 February 2024] in Nature, has identified the potential thresholds of these stressors, showing where their combined effects could produce a ‘tipping point’ - in which the forest is so fragile that just a small disturbance could cause an abrupt shift in the state of the ecosystem.
The study was led by the Federal University ...
Cognitive symptoms of post–COVID-19 condition and daily functioning
2024-02-14
About The Study: The findings of this survey study of U.S. adults suggest that cognitive symptoms are common among individuals with post–COVID-19 condition and associated with greater self-reported functional impairment, lesser likelihood of full-time employment, and greater depressive symptom severity. Screening for and addressing cognitive symptoms is an important component of the public health response to post–COVID-19 condition.
Authors: Roy H. Perlis, M.D., M.Sc., of Massachusetts General Hospital in Boston, is the corresponding ...
Prescription opioid exposure during pregnancy and risk of spontaneous preterm delivery
2024-02-14
About The Study: In this study of 251,000 pregnant patients with Tennessee Medicaid and without opioid use disorder, a positive association was found between total prescription opioid dose dispensed and the odds of spontaneous preterm birth. These findings support guidance to minimize opioid exposure during pregnancy and prescribe the lowest dose necessary.
Authors: Sarah S. Osmundson, M.D., M.S., of the Vanderbilt University Medical Center in Nashville, is the corresponding author.
To access the embargoed study: Visit our For The Media ...
Researchers characterize the immune landscape in cancer
2024-02-14
New York, NY [February 14, 2024]—Researchers from the Icahn School of Medicine at Mount Sinai, in collaboration with the Clinical Proteomic Tumor Analysis Consortium of the National Institutes of Health, The University of Texas MD Anderson Cancer Center, Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, and others, have unveiled a detailed understanding of immune responses in cancer, marking a significant development in the field. The findings were published in the February ...
Altermagnetism proves its place on the magnetic family tree
2024-02-14
There is now a new addition to the magnetic family: thanks to experiments at the Swiss Light Source SLS, researchers have proved the existence of altermagnetism. The experimental discovery of this new branch of magnetism is reported in Nature and signifies new fundamental physics, with major implications for spintronics.
Magnetism is a lot more than just things that stick to the fridge. This understanding came with the discovery of antiferromagnets nearly a century ago. Since then, the family of magnetic materials has been divided into two fundamental phases: the ferromagnetic branch known for several millennia and the antiferromagnetic branch. The experimental proof of a third branch of ...
A “quantum leap” at room temperature
2024-02-14
In the realm of quantum mechanics, the ability to observe and control quantum phenomena at room temperature has long been elusive, especially on a large or “macroscopic” scale. Traditionally, such observations have been confined to environments near absolute zero, where quantum effects are easier to detect. But the requirement for extreme cold has been a major hurdle, limiting practical applications of quantum technologies.
Now, a study led by Tobias J. Kippenberg and Nils Johan Engelsen at EPFL, redefines the boundaries of what’s ...